Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$12.08 - $18.56 $205,021 - $315,000
-16,972 Reduced 13.33%
110,366 $1.85 Million
Q4 2023

Feb 13, 2024

SELL
$16.25 - $20.23 $889,102 - $1.11 Million
-54,714 Reduced 30.05%
127,338 $2.31 Million
Q1 2023

May 11, 2023

SELL
$13.02 - $19.87 $759,573 - $1.16 Million
-58,339 Reduced 24.27%
182,052 $2.37 Million
Q3 2022

Nov 14, 2022

BUY
$8.63 - $15.52 $135,982 - $244,548
15,757 Added 7.01%
240,391 $2.13 Million
Q2 2022

Aug 11, 2022

BUY
$8.59 - $20.77 $287,576 - $695,338
33,478 Added 17.51%
224,634 $2.84 Million
Q4 2021

Feb 11, 2022

BUY
$28.89 - $35.33 $956,316 - $1.17 Million
33,102 Added 20.94%
191,156 $6.71 Million
Q2 2021

Aug 11, 2021

BUY
$23.7 - $39.27 $387,850 - $642,653
16,365 Added 11.55%
158,054 $6.21 Million
Q1 2021

May 13, 2021

BUY
$27.01 - $36.8 $1.53 Million - $2.08 Million
56,634 Added 66.59%
141,689 $4 Million
Q3 2020

Nov 13, 2020

SELL
$25.8 - $34.61 $643,813 - $863,657
-24,954 Reduced 22.68%
85,055 $2.75 Million
Q2 2020

Aug 06, 2020

BUY
$17.65 - $28.05 $181,477 - $288,410
10,282 Added 10.31%
110,009 $3.03 Million
Q1 2020

May 15, 2020

BUY
$15.19 - $29.51 $1.51 Million - $2.94 Million
99,727 New
99,727 $1.78 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.